tiprankstipranks
Advertisement
Advertisement

PCRX Stock Latest News

Pacira Therapeutics: PCRX-201 Progress and Key ASCEND Catalysts Support Buy Rating; $32 Price Target Reaffirmed
RatingsPacira Therapeutics: PCRX-201 Progress and Key ASCEND Catalysts Support Buy Rating; $32 Price Target Reaffirmed
4d ago
PCRX
Pacira transitions PCRX-201 to a U.S.-based manufacturing process
PremiumThe Fly
Pacira transitions PCRX-201 to a U.S.-based manufacturing process
5d ago
PCRX
Pacira announces UnitedHealth provides separate reimbursement for Exparel
PremiumThe Fly
Pacira announces UnitedHealth provides separate reimbursement for Exparel
1M ago
UNH
PCRX
Pacira Buy Rating Reiterated as Strategic Refocus Supports Unchanged $32 Price Target
PremiumRatings
Pacira Buy Rating Reiterated as Strategic Refocus Supports Unchanged $32 Price Target
1M ago
PCRX
Pacira BioSciences Divests CryoTech to Zimmer Biomet
PremiumCompany Announcements
Pacira BioSciences Divests CryoTech to Zimmer Biomet
1M ago
8K
PCRX
Pacira Zimmer to divest iovera degrees to Biomet for $70M upfront
PremiumThe FlyPacira Zimmer to divest iovera degrees to Biomet for $70M upfront
1M ago
ZBH
PCRX
Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
Premium
Company Announcements
Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
2M ago
8K
PCRX
Glass Lewis recommends shareholders vote for Pacira director nominees
Premium
The Fly
Glass Lewis recommends shareholders vote for Pacira director nominees
2M ago
PCRX
Pacira study shows Exparel reduces opioid use and costs
PremiumThe Fly
Pacira study shows Exparel reduces opioid use and costs
2M ago
PCRX
Pacira issues statement on DOMA’s ‘misleading’ statements
PremiumThe Fly
Pacira issues statement on DOMA’s ‘misleading’ statements
2M ago
PCRX
Doma Perpetual urges Pacira shareholders to vote for its board candidates
PremiumThe Fly
Doma Perpetual urges Pacira shareholders to vote for its board candidates
2M ago
PCRX
Doma Perpetual urges Pacira shareholders to vote for its board candidates
PremiumThe Fly
Doma Perpetual urges Pacira shareholders to vote for its board candidates
3M ago
PCRX
Pacira Earnings Call Highlights Growth, Pipeline Momentum
PremiumCompany AnnouncementsPacira Earnings Call Highlights Growth, Pipeline Momentum
3M ago
PCRX
Pacira price target raised to $32 from $30 at Needham
Premium
The Fly
Pacira price target raised to $32 from $30 at Needham
3M ago
PCRX
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
Premium
AI Analyst Ratings
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
3M ago
PCRX
Pacira reports Q1 EPS 60c, consensus 56c
PremiumThe Fly
Pacira reports Q1 EPS 60c, consensus 56c
3M ago
PCRX
Pacira backs FY26 revenue view $745M-$770M, consensus $760.65M
PremiumThe Fly
Pacira backs FY26 revenue view $745M-$770M, consensus $760.65M
3M ago
PCRX
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
PCRX
Exparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
PremiumRatings
Exparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
4M ago
PCRX
Pacira real-world data clearer in hip arthroplasty, says H.C. Wainwright
PremiumThe FlyPacira real-world data clearer in hip arthroplasty, says H.C. Wainwright
4M ago
PCRX
Pacira presents data showing lower healthcare costs for Exparel
Premium
The Fly
Pacira presents data showing lower healthcare costs for Exparel
4M ago
PCRX
Pacira price target lowered to $25 from $27 at Barclays
Premium
The Fly
Pacira price target lowered to $25 from $27 at Barclays
4M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >